Upside:
- OSIS +5.5% (earnings)
- ITMN +36% (to be acquired by Roche @$74/shr in all cash deal)
- BKW +15% (in talks to acquire Tim Hortons)
- THI +15% (in talks w/BKW for potential acquisition)
- X +3.5% (Credit Suisse raises to Outperform from Underperform)
- DGLY +18% (follow thru momentum from Ferguson riots)
- ANN +3% (shareholder Engine Capital believes company could be worth up to $55/shr)
- GIMO +4.7% (announced collaboration w/VMWare NSX and Software-Defined Data Center)
- INSY +6.1% (receives FDA Orphan Drug Designation for Pharmaceutical Cannabidiol for GBM)
- DRL +1.4% (updates discussions w/Treasury of Puerto Rico; proposed framework for settlement)
- ADXS +4.6% (announced advanced prostate cancer collaboration agreement w/Merck)
- TOPS +6.4% (announced extended charter and increased rate for M/T EShips Taweelah)
- LTM +9% (exploring REIT conversion)
Downside:
- QIHU -4.2% (earnings)
- GEF -10% (guides FY14 lower)
- RGDO -43% (permanently halts Regulate-PCI Phase III clinical trial for Revolixys Kit)
General Risk Warning for stocks, cryptocurrencies, ETP, FX & CFD Trading. Investment assets are leveraged products. Trading related to foreign exchange, commodities, financial indices, stocks, ETP, cryptocurrencies, and other underlying variables carry a high level of risk and can result in the loss of all of your investment. As such, variable investments may not be appropriate for all investors. You should not invest money that you cannot afford to lose. Before deciding to trade, you should become aware of all the risks associated with trading, and seek advice from an independent and suitably licensed financial advisor. Under no circumstances shall Witbrew LLC and associates have any liability to any person or entity for (a) any loss or damage in whole or part caused by, resulting from, or relating to any transactions related to investment trading or (b) any direct, indirect, special, consequential or incidental damages whatsoever.
Recommended Content
Editors’ Picks
EUR/USD holds firm above 1.0700 ahead of German inflation data
EUR/USD trades on a firm footing above 1.0700 early Monday. The pair stays underpinned by a softer US Dollar, courtesy of the USD/JPY sell-off and a risk-friendly market environment. Germany's inflation data is next in focus.
USD/JPY recovers after testing 155.00 on likely Japanese intervention
USD/JPY is recovering ground after crashing to 155.00 on what seemed like a Japanese FX intervention. The Yen tumbled in early trades amid news that Japan's PM lost 3 key seats in the by-election. Holiday-thinned trading exaggerates the USD/JPY price action.
Gold price bulls move to the sidelines as focus shifts to the crucial FOMC policy meeting
Gold price (XAU/USD) struggles to capitalize on its modest gains registered over the past two trading days and edges lower on the first day of a new week, albeit the downside remains cushioned.
Ripple CTO shares take on ETHgate controversy, XRP holders await SEC opposition brief filing
Ripple loses all gains from the past seven days, trading at $0.50 early on Monday. XRP holders have their eyes peeled for the Securities and Exchange Commission filing of opposition brief to Ripple’s motion to strike expert testimony.
Week ahead: FOMC and jobs data in sight
May kicks off with the Federal Open Market Committee meeting and will be one to watch, scheduled to make the airwaves on Wednesday. It’s pretty much a sealed deal for a no-change decision at this week’s meeting.